Table 1 IOP, BCVA and the number of antiglaucoma medications for NVG patients

baseline

52

48.1 ± 14.2

2.3 ± 1.1

3.0 (3.0, 4.0)

after injection

52

44.3 ± 14.0

2.2 ± 1.1

3.0 (3.0, 4.0)

1 day

52

19.5 ± 10.6^a

2.2 ± 1.1

0.0 (0.0, 0.0)^a

1 week

49

16.1 ± 9.3^a

1.9 ± 1.0

0.0 (0.0, 0.0)^a

1 month

42

20.2 ± 8.9^a

2.0 ± 1.1

0.0 (0.0, 0.0)^a

3 months

40

23.1 ± 10.6^a

2.0 ± 1.2

0.0 (0.0, 0.8)^a

6 months

39

25.1 ± 8.6^a

2.0 ± 1.2

0.0 (0.0, 1.0)^a

1 year

39

23.2 ± 8.7^a

2.1 ± 1.2

1.0 (0.0, 1.0)^a

F/χ ²

878.486

163.157

294.232

P

0.000

0.000

0.000